Back to trial details

Intake questionnaire

VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma

Applying to The George Washington University Cancer Center (site 212) · Washington D.C., District of Columbia

Answer a few short questions to share with the research team.

0 of 3 answered

1. Are you between 18 and 80 years old?
2. Have you been diagnosed with Head and Neck Carcinoma?
3. Are you able to travel to Washington D.C. for study visits?